These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31824306)

  • 1. RU486 Metabolite Inhibits CCN1/Cyr61 Secretion by MDA-MB-231-Endothelial Adhesion.
    Yu S; Yan C; Wu W; He S; Liu M; Liu J; Yang X; Ma J; Lu Y; Jia L
    Front Pharmacol; 2019; 10():1296. PubMed ID: 31824306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoproteomic analysis reveals that metapristone (RU486 metabolite) intervenes E-cadherin and vimentin to realize cancer metastasis chemoprevention.
    Yu S; Yan C; Yang X; He S; Liu J; Qin C; Huang C; Lu Y; Tian Z; Jia L
    Sci Rep; 2016 Mar; 6():22388. PubMed ID: 26932781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention.
    Zheng N; Chen J; Li T; Liu W; Liu J; Chen H; Wang J; Jia L
    Mol Carcinog; 2017 Aug; 56(8):1896-1908. PubMed ID: 28277622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis.
    Huang YT; Lan Q; Lorusso G; Duffey N; Rüegg C
    Oncotarget; 2017 Feb; 8(6):9200-9215. PubMed ID: 27911269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyr61 as mediator of Src signaling in triple negative breast cancer cells.
    Sánchez-Bailón MP; Calcabrini A; Mayoral-Varo V; Molinari A; Wagner KU; Losada JP; Ciordia S; Albar JP; Martín-Pérez J
    Oncotarget; 2015 May; 6(15):13520-38. PubMed ID: 25980494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo efficacy and safety evaluation of metapristone and mifepristone as cancer metastatic chemopreventive agents.
    Wang J; Chen J; Zhu Y; Zheng N; Liu J; Xiao Y; Lu Y; Dong H; Xie J; Yu S; Shao J; Jia L
    Biomed Pharmacother; 2016 Mar; 78():291-300. PubMed ID: 26898454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, spectral characterization, and in vitro cellular activities of metapristone, a potential cancer metastatic chemopreventive agent derived from mifepristone (RU486).
    Wang J; Chen J; Wan L; Shao J; Lu Y; Zhu Y; Ou M; Yu S; Chen H; Jia L
    AAPS J; 2014 Mar; 16(2):289-98. PubMed ID: 24442753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of soluble E-selectin on tumor progression and metastasis.
    Kang SA; Blache CA; Bajana S; Hasan N; Kamal M; Morita Y; Gupta V; Tsolmon B; Suh KS; Gorenstein DG; Razaq W; Rui H; Tanaka T
    BMC Cancer; 2016 May; 16():331. PubMed ID: 27220365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles for GP IIb/IIIa and αvβ3 integrins in MDA-MB-231 cell invasion and shear flow-induced cancer cell mechanotransduction.
    Zhao F; Li L; Guan L; Yang H; Wu C; Liu Y
    Cancer Lett; 2014 Mar; 344(1):62-73. PubMed ID: 24176823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer.
    Vellon L; Menendez JA; Lupu R
    Oncogene; 2005 May; 24(23):3759-73. PubMed ID: 15782133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embedding similarities between embryos and circulating tumor cells: fundamentals of abortifacients used for cancer metastasis chemoprevention.
    Wang J; Yu X; Peng H; Lu Y; Li S; Shi Q; Liu J; Dong H; Katanaev V; Jia L
    J Exp Clin Cancer Res; 2021 Sep; 40(1):300. PubMed ID: 34556175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norepinephrine promotes the β1-integrin-mediated adhesion of MDA-MB-231 cells to vascular endothelium by the induction of a GROα release.
    Strell C; Niggemann B; Voss MJ; Powe DG; Zänker KS; Entschladen F
    Mol Cancer Res; 2012 Feb; 10(2):197-207. PubMed ID: 22127496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metapristone suppresses non-small cell lung cancer proliferation and metastasis via modulating RAS/RAF/MEK/MAPK signaling pathway.
    Zheng G; Shen Z; Chen H; Liu J; Jiang K; Fan L; Jia L; Shao J
    Biomed Pharmacother; 2017 Jun; 90():437-445. PubMed ID: 28391165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveolin-1-containing extracellular vesicles transport adhesion proteins and promote malignancy in breast cancer cell lines.
    Campos A; Salomon C; Bustos R; Díaz J; Martínez S; Silva V; Reyes C; Díaz-Valdivia N; Varas-Godoy M; Lobos-González L; Quest AF
    Nanomedicine (Lond); 2018 Oct; 13(20):2597-2609. PubMed ID: 30338706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tryptophan hydroxylase 1 and 5-HT
    Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
    Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells.
    Cook MT; Liang Y; Besch-Williford C; Hyder SM
    Breast Cancer (Dove Med Press); 2017; 9():9-19. PubMed ID: 28096694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH.
    Gründker C; Bauerschmitz G; Schubert A; Emons G
    Int J Oncol; 2016 Jun; 48(6):2713-21. PubMed ID: 27098123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.